7/ How often do you read a tweetorial all the way through?
Most respondents (87%) "always" or "often" read a tweetorial all the way through.
What makes people stop? The number one answer (selected by 38% of respondents) was "it goes on too long”.
8/ What is the optimal tweetorial length?
Tweet 7 suggests that a tweetorial's length matters. What was the suggested optimal number of tweets?
12
Though most prefer 10-15 tweets per tweetorial, you can see from the figure that there is an audience for longer ones.
9/
I looked at this data and didn't see any differences based on role or age.
The only thing that seemed to matter: if you "rarely" completed a tweetorial, you were more likely to prefer a shorter one, compared with those who "always" did (10 tweets versus 14).
10/ Approximately how many times have you bookmarked or otherwise collected a tweetorial for later use?
Although 88% of respondents had read more than 5 tweetorials, few collect them. 25% had collected zero and 64% had collected 5 or fewer.
This remains an area of great need.
11/ The free text responses support the idea that one main limitation of this platform is that content can easily be "lost".
Partially in response to this survey, I'll be working with others on the @MedTweetorials project. More information to come on this in future weeks.
12/ Should tweetorials be peer reviewed?
33% responded yes. I did not ask a follow-up question about what this process might look like.
Also, there were no clear differences based on role or whether one has written a tweetorial.
13/ What is the best comparison for a tweetorial?
Nearly half (47%) see tweetorials as lectures.
Unsurprisingly, if you view a tweetorial as a form of peer-reviewed research, you're more likely to think it should be peer-reviewed (66% versus 32% for "lecture”).
14/ Have you (how many) tweetorials have you posted?
About 1 in 7 (14%) of respondents have posted a tweetorial. That’s 82 people.
59% have written 3 or fewer with 18 having written 1.
One need not make this a full-time job to be a valuable contributor!
15/15
Those are some of the key results of the survey.
If you're interested in reviewing the full set of anonymous data, you can see it here (I have left out free-text answers):
You are seeing a patient recently diagnosed with heart failure and started on GDMT. You notice that their hemoglobin (HGB) has increased (12 → 13 g/dL) in the intervening weeks.
🤔Which medication is the likely cause of this increase in HGB?
2/12 - An Answer
Empagliflozin
💡All SGLT2 inhibitors have been associated with an increase in hematocrit/hemoglobin soon after initiation.
The average increase is 2.3% in hematocrit and 0.6 g/dL in hemoglobin.
The effect of SGLT2 inhibitors on HCT/HGB has been noted since the very first randomized control trial of dapagliflozin, published in 2010.
Initially, investigators assumed this was related to the diuretic effect of these drugs (i.e., a reduction in plasma volume led to an increase in HCT/HGB).
3/ The mutation in the Factor V gene conferring resistance to activated protein C was detailed the following year by a group in Leiden, The Netherlands.